In the Review article “Pimavanserin: A novel therapeutic option for Parkinson disease psychosis” by T. Hawkins and B.D. Berman,1 there are 2 minor errors. The last sentence in the third paragraph under “Development of pimavanserin” should have read “In addition, pimavanserin did not affect motor symptom severity and led to significant decreases in caregiver burden and improvements in nighttime sleep and daytime wakefulness.” The second-to-last sentence under “Prescribing information” should read “In the positive phase 3 trial of pimavanserin detailed above, there were 3 deaths; 2 in the treatment group and 1 in the placebo group.” The authors regret the errors.
- © 2017 American Academy of Neurology
REFERENCE
- 1.↵
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.